Physician profile
Olivia Taylor
NPI 1932661865
$1,239.04
in general payments reported to CMS, 2019-2025
14 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $613 · 2024: $322 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.08 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $257.81 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $180.96 | 2023 | Slynd |
| Mayne Pharma Commercial LLC | $172.05 | 2023-2024 | |
| Evofem Biosciences, INC. | $120.65 | 2023-2025 | Phexxi, Solosec, Phexx |
| Aspira Women'S Health INC | $117.72 | 2022 | |
| Novo Nordisk INC | $96.10 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $69.92 | 2023-2024 | |
| Exact Sciences Corporation | $59.32 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $46.04 | 2023-2025 | |
| Pfizer INC. | $32.04 | 2023-2024 | |
| Millicent US INC | $23.68 | 2025 | Femlyv |
| Daiichi Sankyo INC. | $23.25 | 2022 | |
| Shield Therapeutics INC | $21.86 | 2024 | |
| Lilly USA, LLC | $17.64 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.